NASDAQ · Healthcare · Biotechnology
Ensysce Biosciences, Inc.
ENSC
Ensysce Biosciences, Inc. CEO D. Lynn Kirkpatrick · Market cap $5.6M.
$0.37
-0.01 · -2.17%
52w hi $2.7552w lo $0.23
Off 52w high 86.0%
65
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 07 | Bob G Gower | Buy | 400,000 | $0.49 | +$198K | 65 | |
| Apr 23 | Bob G Gower | Buy | 508,614 | $0.48 | +$246K | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug